Colin J. Chu

Colin J. Chu

Auto-generated profile, based on publicly available information

Colin J. Chu

Academic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Ophthalmology
Verified
Journal Article
Open access
CCColin J. Chu
Colin J. Chu
RJRobert L. Johnston
Robert L. Johnston
CBCharlotte Buscombe
Charlotte Buscombe
ASAhmed B. Sallam
Ahmed B. Sallam
QMQueresh Mohamed
Queresh Mohamed
YYYit C. Yang
Yit C. Yang
To define the incidence of pseudophakic macular edema (PME) after cataract surgery and to identify contributory risk factors. Retrospective database study of electronic medical records (EMRs). A total of 81984 eyes undergoing cataract surgery between December 2010 and December 2014 from 8 independent United Kingdom clinical sites. Structured clinical data mandated by the EMR were anonymized and extracted for each eye undergoing cataract surgery including: perioperative visual acuity, copathologic features, simultaneous surgical procedures, and the presence or absence of a specified list of intraoperative complications. Diabetic status with matched Early Treatment Diabetic Retinopathy Study (ETDRS) grading also was mandated by the EMR. Eyes receiving prophylactic nonsteroidal anti-inflammatory drugs were excluded. Diagnosis of cystoid macular edema or new-onset macular edema in patients with diabetes, recorded by a healthcare professional within 90 days of surgery. Baseline incidence of PME in eyes without operative complications, diabetes, or risk factors was 1.17%. Eyes in which PME developed were more likely to be male, older, and to demonstrate risk factors. The relative risk (RR) was increased in eyes with capsule rupture with or without vitreous loss (RR, 2.61; 95% confidence interval [CI], 1.57-4.34), a previous diagnosis of epiretinal membrane (RR, 5.60; 95% CI, 3.45-9.07), uveitis (RR, 2.88; 95% CI, 1.50-5.51), retinal vein occlusion (RR, 4.47; 95% CI, 2.56-5.92), or retinal detachment repair (RR, 3.93; 95% CI, 2.60-5.92). High myopia, age-related macular degeneration, or prostaglandin analog use were not shown to increase risk. Eyes with PME on average had poorer postoperative visual acuity, which persisted to the latest time point assessed, up to 24 weeks. Eyes from patients with diabetes, even in the absence of retinopathy, had an increased RR (RR, 1.80; 95% CI, 1.36-2.36) of new macular edema after surgery. The risk was higher in the presence of any diabetic retinopathy (DR; RR, 6.23; 95% CI, 5.12-7.58) and rose proportionately with increasing severity of DR. Pseudophakic macular edema occurs commonly after phacoemulsification cataract surgery, even in the absence of complications and risk factors. This large retrospective study using structured EMR data quantified the RRs of PME and the risk with increasing ETDRS severity of DR. It highlights the need for prophylactic therapy, especially in those groups of eyes with the highest RRs.

21 July 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
AGAnai Gonzalez-Cordero
Anai Gonzalez-Cordero
EWEmma L West
Emma L West
RPRachael A Pearson
Rachael A Pearson
YDYanai Duran
Yanai Duran
Livia S CarvalhoLivia S Carvalho
Livia S Carvalho
RARobin R Ali
Robin R Ali
Optic cup-like structures generated from mouse ES cells produce photoreceptor precursors that integrate and mature in vivo in three models of retinal degeneration. Irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy. We previously demonstrated retinal repair1 and restoration of vision through transplantation of photoreceptor precursors obtained from postnatal retinas into visually impaired adult mice2,3. Considerable progress has been made in differentiating embryonic stem cells (ESCs) in vitro toward photoreceptor lineages4,5,6. However, the capability of ESC-derived photoreceptors to integrate after transplantation has not been demonstrated unequivocally. Here, to isolate photoreceptor precursors fit for transplantation, we adapted a recently reported three-dimensional (3D) differentiation protocol that generates neuroretina from mouse ESCs6. We show that rod precursors derived by this protocol and selected via a GFP reporter under the control of a Rhodopsin promoter integrate within degenerate retinas of adult mice and mature into outer segment–bearing photoreceptors. Notably, ESC-derived precursors at a developmental stage similar to postnatal days 4–8 integrate more efficiently compared with cells at other stages. This study shows conclusively that ESCs can provide a source of photoreceptors for retinal cell transplantation.

21 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ARAndrea J. Radtke
Andrea J. Radtke
EKEvelyn Kandov
Evelyn Kandov
BLBradley Lowekamp
Bradley Lowekamp
ESEmily Speranza
Emily Speranza
CCColin J. Chu
Colin J. Chu
RGRonald N. Germain
Ronald N. Germain
Significance: Single-cell flow cytometry and genomic methods are rapidly increasing our knowledge of the diversity of cell types in metazoan tissues. However, suitably robust methods for placing these cells in a spatial context that reveals how their localization and putative interactions contribute to tissue physiology and pathology are still lacking. Here we provide a readily accessible pipeline (IBEX) for highly multiplex immunofluorescent imaging that enables a fine-grained analysis of cells in their tissue context. Additionally, we describe extensions of the IBEX workflow to handle hard-to-image tissue preparations and a method to facilitate direct integration of the imaging data with flow cytometry and sequencing technologies.

10 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
YCYing Kai Chan
Ying Kai Chan
SWSean K. Wang
Sean K. Wang
CCColin J. Chu
Colin J. Chu
DCDavid A. Copland
David A. Copland
ALAlexander J. Letizia
Alexander J. Letizia
GCGeorge Church
George Church
Incorporating TLR9-inhibitory sequences in the AAV vector genome inhibits immunogenicity and enhances transgene expression in multiple animal models.

12 January 2022 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
ARAndrea J. Radtke
Andrea J. Radtke
CCColin J. Chu
Colin J. Chu
ZYZiv Yaniv
Ziv Yaniv
LYLi Yao
Li Yao
JMJames Marr
James Marr
RGRonald N. Germain
Ronald N. Germain

1 March 2020 in Molecular Therapy
Verified
Journal Article
Open access
JWJiahui Wu
Jiahui Wu
OBOliver H. Bell
Oliver H. Bell
DCDavid A. Copland
David A. Copland
AYAlison Young
Alison Young
JPJohn R. Pooley
John R. Pooley
CCColin J. Chu
Colin J. Chu
Glaucoma is a common cause of blindness, yet current therapeutic options are imperfect. Clinical trials have invariably shown that reduction in intraocular pressure (IOP) regardless of disease subtype prevents visual loss. Reducing ciliary body aqueous humor production can lower IOP, and the adeno-associated virus ShH10 serotype was identified as able to transduce mouse ciliary body epithelium following intravitreal injection. Using ShH10 to deliver a single vector CRISPR-Cas9 system disrupting Aquaporin 1 resulted in reduced IOP in treated eyes (10.4 ± 2.4 mmHg) compared with control (13.2 ± 2.0 mmHg) or non-injected eyes (13.1 ± 2.8 mmHg; p < 0.001; n = 12). Editing in the aquaporin 1 gene could be detected in ciliary body, and no off-target increases in corneal or retinal thickness were identified. In experimental mouse models of corticosteroid and microbead-induced ocular hypertension, IOP could be reduced to prevent ganglion cell loss (32 ± 4 /mm2) compared with untreated eyes (25 ± 5/mm2; p < 0.01). ShH10 could transduce human ciliary body from post-mortem donor eyes in ex vivo culture with indel formation detectable in the Aquaporin 1 locus. Clinical translation of this approach to patients with glaucoma may permit long-term reduction of IOP following a single injection.